Yatabe Y - Search Results

1

Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers.

Osada H, Tatematsu Y, Yatabe Y, Nakagawa T, Konishi H, Harano T, Tezel E, Takada M, Takahashi T. Osada H, et al. Among authors: yatabe y. Oncogene. 2002 Apr 4;21(15):2418-24. doi: 10.1038/sj.onc.1205303. Oncogene. 2002. PMID: 11948426

2

Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers.

Mizuno K, Osada H, Konishi H, Tatematsu Y, Yatabe Y, Mitsudomi T, Fujii Y, Takahashi T. Mizuno K, et al. Among authors: yatabe y. Oncogene. 2002 Apr 4;21(15):2328-33. doi: 10.1038/sj.onc.1205402. Oncogene. 2002. PMID: 11948416

3

TTF-1 expression in pulmonary adenocarcinomas.

Yatabe Y, Mitsudomi T, Takahashi T. Yatabe Y, et al. Am J Surg Pathol. 2002 Jun;26(6):767-73. doi: 10.1097/00000478-200206000-00010. Am J Surg Pathol. 2002. PMID: 12023581

4

Increased expression of COX-2 in the development of human lung cancers.

Takahashi T, Kozaki K, Yatabe Y, Achiwa H, Hida T. Takahashi T, et al. Among authors: yatabe y. J Environ Pathol Toxicol Oncol. 2002;21(2):177-81. J Environ Pathol Toxicol Oncol. 2002. PMID: 12086404

5

Decreased expression of 14-3-3sigma in neuroendocrine tumors is independent of origin and malignant potential.

Yatabe Y, Osada H, Tatematsu Y, Mitsudomi T, Takahashi T. Yatabe Y, et al. Oncogene. 2002 Nov 28;21(54):8310-9. doi: 10.1038/sj.onc.1206014. Oncogene. 2002. PMID: 12447694

6

Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer.

Konishi H, Sugiyama M, Mizuno K, Saito H, Yatabe Y, Takahashi T, Osada H, Takahashi T. Konishi H, et al. Among authors: yatabe y. Oncogene. 2003 Mar 27;22(12):1892-905. doi: 10.1038/sj.onc.1206304. Oncogene. 2003. PMID: 12660825

7

RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication.

Endoh H, Yatabe Y, Shimizu S, Tajima K, Kuwano H, Takahashi T, Mitsudomi T. Endoh H, et al. Among authors: yatabe y. Int J Cancer. 2003 Aug 10;106(1):45-51. doi: 10.1002/ijc.11184. Int J Cancer. 2003. PMID: 12794755

8

Prognostic models in patients with non-small-cell lung cancer using artificial neural networks in comparison with logistic regression.

Hanai T, Yatabe Y, Nakayama Y, Takahashi T, Honda H, Mitsudomi T, Kobayashi T. Hanai T, et al. Among authors: yatabe y. Cancer Sci. 2003 May;94(5):473-7. doi: 10.1111/j.1349-7006.2003.tb01467.x. Cancer Sci. 2003. PMID: 12824896 Free PMC article.

9

The sensitivity of lung cancer cell lines to the EGFR-selective tyrosine kinase inhibitor ZD1839 ('Iressa') is not related to the expression of EGFR or HER-2 or to K-ras gene status.

Suzuki T, Nakagawa T, Endo H, Mitsudomi T, Masuda A, Yatabe Y, Sugiura T, Takahashi T, Hida T. Suzuki T, et al. Among authors: yatabe y. Lung Cancer. 2003 Oct;42(1):35-41. doi: 10.1016/s0169-5002(03)00278-2. Lung Cancer. 2003. PMID: 14512185

10

Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction.

Endoh H, Tomida S, Yatabe Y, Konishi H, Osada H, Tajima K, Kuwano H, Takahashi T, Mitsudomi T. Endoh H, et al. Among authors: yatabe y. J Clin Oncol. 2004 Mar 1;22(5):811-9. doi: 10.1200/JCO.2004.04.109. J Clin Oncol. 2004. PMID: 14990636

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

767 results

Search Page

Filters